Literature DB >> 19508837

Clinical and molecular characteristics of gastrointestinal stromal tumors in the pediatric and young adult population.

Lori Rink1, Andrew K Godwin.   

Abstract

Gastrointestinal stromal tumors (GISTs) typically occur late in life; however, there also are reports of pediatric and young adult patients. This rare subset of GISTs has clinicopathologic and molecular features distinct from their adult counterparts. Most pediatric GIST patients are female and often present with multifocal tumors that are epithelioid in nature. Although these young patients often have metastatic disease, it progresses slowly. Most pediatric GISTs lack the gain-of-function mutation in KIT or PDGFRA commonly found in adult cases. Expression profiling and genomic studies of pediatric GISTs show distinct molecular signatures, suggesting a unique origin as compared with adult GISTs. We and others have shown that the insulin-like growth factor 1 receptor may have a prominent role in driving KIT/PDGFRA mutation-negative adult and pediatric GISTs, and clinical trials are currently being designed to exploit these types of discoveries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508837      PMCID: PMC2822338          DOI: 10.1007/s11912-009-0044-0

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  40 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.

Authors:  L G Kindblom; H E Remotti; F Aldenborg; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma.

Authors:  J A Carney; S G Sheps; V L Go; H Gordon
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

4.  Stromal tumors of the jejunum and ileum.

Authors:  J A Tworek; H D Appelman; T P Singleton; J K Greenson
Journal:  Mod Pathol       Date:  1997-03       Impact factor: 7.842

5.  Gastric stromal tumors. Reappraisal of histogenesis.

Authors:  M T Mazur; H B Clark
Journal:  Am J Surg Pathol       Date:  1983-09       Impact factor: 6.394

6.  Pediatric gastrointestinal stromal tumors and leiomyosarcoma.

Authors:  Monica S Cypriano; Jesse J Jenkins; Alberto S Pappo; Bhaskar N Rao; Najat C Daw
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

Review 7.  Biology of gastrointestinal stromal tumors.

Authors:  Christopher L Corless; Jonathan A Fletcher; Michael C Heinrich
Journal:  J Clin Oncol       Date:  2004-09-15       Impact factor: 44.544

8.  Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.

Authors:  Bernadette Liegl; Jason L Hornick; Christopher L Corless; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

9.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Charles D Blanke; Annick D Van den Abbeele; Burton Eisenberg; Peter J Roberts; Michael C Heinrich; David A Tuveson; Samuel Singer; Milos Janicek; Jonathan A Fletcher; Stuart G Silverman; Sandra L Silberman; Renaud Capdeville; Beate Kiese; Bin Peng; Sasa Dimitrijevic; Brian J Druker; Christopher Corless; Christopher D M Fletcher; Heikki Joensuu
Journal:  N Engl J Med       Date:  2002-08-15       Impact factor: 91.245

10.  Epithelioid gastrointestinal stromal tumor of the stomach with liver metastases in a 12-year-old girl: aspiration cytology and molecular study.

Authors:  Peng Li; Jianjun Wei; A Brian West; MaryAnn Perle; M Alba Greco; Grace C H Yang
Journal:  Pediatr Dev Pathol       Date:  2002-06-17
View more
  12 in total

1.  Bench to bedside and back again: personalizing treatment for patients with GIST.

Authors:  Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2011-11       Impact factor: 6.261

2.  Drug repurposing for gastrointestinal stromal tumor.

Authors:  Ziyan Y Pessetto; Scott J Weir; Geetika Sethi; Melinda A Broward; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2013-05-08       Impact factor: 6.261

3.  Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.

Authors:  Ziyan Y Pessetto; Yan Ma; Jeff J Hirst; Margaret von Mehren; Scott J Weir; Andrew K Godwin
Journal:  Mol Cancer Ther       Date:  2014-08-13       Impact factor: 6.261

Review 4.  Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.

Authors:  Hani J Alturkmani; Ziyan Y Pessetto; Andrew K Godwin
Journal:  Expert Opin Investig Drugs       Date:  2015-06-22       Impact factor: 6.206

5.  Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.

Authors:  Phillip Zook; Harsh B Pathak; Martin G Belinsky; Lawrence Gersz; Karthik Devarajan; Yan Zhou; Andrew K Godwin; Margaret von Mehren; Lori Rink
Journal:  Clin Cancer Res       Date:  2016-07-01       Impact factor: 12.531

6.  Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.

Authors:  Safinur Atay; Samagya Banskota; Jennifer Crow; Geetika Sethi; Lori Rink; Andrew K Godwin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

7.  Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Margaret von Mehren
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

8.  Post-transcriptional dysregulation by miRNAs is implicated in the pathogenesis of gastrointestinal stromal tumor [GIST].

Authors:  Lorna Kelly; Kenneth Bryan; Su Young Kim; Katherine A Janeway; J Keith Killian; Hans-Ulrich Schildhaus; Markku Miettinen; Lee Helman; Paul S Meltzer; Matt van de Rijn; Maria Debiec-Rychter; Maureen O'Sullivan
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

9.  Colonic gastrointestinal stromal tumour presenting as intussusception.

Authors:  Simmi K Ratan; Garima Goel; Parul Sobti; Nita Khurana; Mohit Mathur; Shandip K Sinha; Satish K Aggarwal
Journal:  APSP J Case Rep       Date:  2013-05-21

Review 10.  Tumor-derived exosomes: A message delivery system for tumor progression.

Authors:  Safinur Atay; Andrew K Godwin
Journal:  Commun Integr Biol       Date:  2014-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.